Target intelligence / Profile preview

Heat shock protein family A member 9 nucleotide-binding domain (HSPA9 NBD)

Target
HSPA9 NBD
Molecular classification
Molecular chaperone, Enzyme (ATPase activity), Heat shock protein (Hsp70 family), Other (nucleotide-binding protein)
01

Overview

The **nucleotide-binding domain (NBD) of heat shock protein family A member 9 (HSPA9)**, commonly known as Mortalin or mitochondrial Hsp70, is a crucial molecular chaperone primarily localized in the mitochondrial matrix. The Mortalin NBD binds and hydrolyzes ATP, driving the conformational changes necessary for the import, folding, and quality control of mitochondria-targeted proteins. Mortalin regulates diverse cellular processes including mitochondrial function, iron-sulfur (Fe-S) cluster biogenesis, p53 localization and activity, apoptosis, and cellular stress response. Genetic mutations within this domain are linked to diseases such as EVEN-PLUS syndrome and have implications in cancer and neurodegeneration. Mortalin’s interaction with tumor suppressor protein p53 is a therapeutic target, exemplified by the investigational compound MKT-077, which disrupts this interaction and sensitizes cancer cells to apoptosis[1][2][3][4][6][7]. The Mortalin NBD is essential for mitochondrial protein homeostasis, and its dysfunction or targeted inhibition can have pleiotropic cellular effects.

Other names
MortalinHSPA9GRP75mtHsp70mitochondrial Hsp70
02

Mechanism of action

Inhibition of ATPase activity of Mortalin NBD; Disruption of Mortalin–p53 interaction; Modulation of mitochondrial stress and apoptosis pathways

03

Biological functions

Mitochondrial protein importProtein foldingProtein quality controlFe-S cluster biogenesisRegulation of p53Mitochondrial homeostasisRegulation of apoptosisCellular stress response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular disease (via mitochondrial dysfunction)Genetic syndromes (e.g., EVEN-PLUS syndrome)
05

Safety considerations

Off-target impact on protein homeostasisPotential mitochondrial toxicity due to impaired import and foldingEffects on cellular viability in non-cancer tissues
06

Interacting drugs

MKT-077 (investigational antitumor agent)
07

Biomarkers

HSPA9/mortalin protein expression (in cancers and some neurodegenerative diseases)

Beyond the preview

Go deeper on Heat shock protein family A member 9 nucleotide-binding domain (HSPA9 NBD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein family A member 9 nucleotide-binding domain (HSPA9 NBD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call